Chimera Gentec Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 09-12-2024
- Paid Up Capital ₹ 0.20 M
as on 09-12-2024
- Company Age 26 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -48.71%
(FY 2020)
- Profit -75.79%
(FY 2020)
- Ebitda -63.48%
(FY 2020)
- Net Worth 2.81%
(FY 2020)
- Total Assets 7.28%
(FY 2020)
About Chimera Gentec
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Aman Chawla and Pcheena Chawla serve as directors at the Company.
- CIN/LLPIN
U24232DL1998PTC092892
- Company No.
092892
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Mar 1998
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Chimera Gentec Private Limited offer?
Chimera Gentec Private Limited offers a wide range of products and services, including Actuarial & Risk Management, Risk Management Services, Welfare Organization Services, Social Collaboration Services, Business Consultant, Process Development Service, Auditing Services.
Who are the key members and board of directors at Chimera Gentec?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pcheena Chawla  | Director | 17-Feb-2022 | Current |
| Aman Chawla | Director | 06-Sep-2020 | Current |
Financial Performance and Corporate Structure Insights of Chimera Gentec.
Chimera Gentec Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 48.71% decrease. The company also saw a substantial fall in profitability, with a 75.79% decrease in profit. The company's net worth moved up by a moderate rise of 2.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chimera Gentec?
In 2020, Chimera Gentec had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bellerophon Biotec Private LimitedActive 12 years 3 monthsAman Chawla and Pcheena Chawla are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chimera Gentec?
Unlock and access historical data on people associated with Chimera Gentec, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chimera Gentec, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chimera Gentec's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
